SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Chugai Pharmaceutical Co., Ltd. CHGCY OTC

Other OTC • Healthcare • Drug Manufacturers - General • JP • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Chugai Pharmaceutical Co., Ltd. (CHGCY) is a Drug Manufacturers - General company in the Healthcare sector, currently trading at $27.20. It has a SharesGrow Score of 88/100, indicating a strong investment profile with 5 out of 7 criteria passed.

Financials: revenue is $1.3T, +2.1%/yr average growth. Net income is $455.1B, growing at +7.8%/yr. Net profit margin is 34.5% (strong). Gross margin is 71.1% (+8.9 pp trend).

Balance sheet: total debt is $25.7B against $2.0T equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 4.23 (strong liquidity). Debt-to-assets is 1%. Total assets: $2.5T.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 55/100 (Partial), Past 100/100 (Pass), Health 100/100 (Pass), Moat 88/100 (Pass), Future ?/100 (Fail), Income 100/100 (Pass).

CHGCY SharesGrow Score Overview

91/100

SharesGrow Score

Strong investment profile

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 55/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 88/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 100/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CHGCY

CHGCY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

CHGCY: +2.1%/yr revenue is, +7.8%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

CHGCY: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet CHGCY: Debt-to-Equity (D/E) ratio 0.01 (conservative), Current ratio is 4.23 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

CHGCY: Gross margin is 71.1% (+8.9 pp trend), $90B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 88/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

CHGCY: Net profit margin is 34.5%. strong (≥30%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range19.5-34.84

Volume35.32K

Avg Volume (30D)217.74K

Market Cap$89.53B

Beta (1Y)0.60

Dividend Yield$0.8218

Share Statistics

EPS (TTM)138.26

Shares Outstanding$3.29B

IPO Date2012-08-03

Employees5,026

CEOOsamu Okuda

Financial Highlights & Ratios

Revenue (TTM)$1.32T

Gross Profit$937.6B

EBITDA$661.98B

Net Income$455.05B

Operating Income$618.8B

Total Cash$980.36B

Total Debt$25.73B

Net Debt$-401.17B

Total Assets$2.47T

Price / Earnings (P/E)0.2

Price / Sales (P/S)0.07

Analyst Forecast

Company Info

CountryJP

ExchangeOther OTC

CurrencyUSD

ISINUS1712691039

Price Chart

CHGCY

Chugai Pharmaceutical Co., Ltd. ↗ · Other OTC

Healthcare • Drug Manufacturers - General

19.50 52WK RANGE 34.84

People Also View

Johnson & Johnson

Roche Holding AG

AstraZeneca PLC

Merck & Co., Inc.

Gilead Sciences, Inc.

Bristol-Myers Squibb Company

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message